Meprotanum en es it fr

Meprotanum Brand names, Meprotanum Analogs

Meprotanum Brand Names Mixture

  • No information avaliable

Meprotanum Chemical_Formula


Meprotanum RX_link

No information avaliable

Meprotanum fda sheet

Meprotanum msds (material safety sheet)

Meprotanum Synthesis Reference

No information avaliable

Meprotanum Molecular Weight

309.469 g/mol

Meprotanum Melting Point

< 25 oC

Meprotanum H2O Solubility

Soluble as HCl salt

Meprotanum State


Meprotanum LogP


Meprotanum Dosage Forms

Tablets (oral, 1 mg)

Meprotanum Indication

Used for the symptomatic treatment of parkinsonism.

Meprotanum Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Meprotanum Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Meprotanum side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Meprotanum Patient Information

Meprotanum Organisms Affected

Humans and other mammals